Ineffective off-label use of recombinant activated factor VII in a case of bone-marrow transplantation-related gastrointestinal bleeding

<p>Abstract</p> <p>Background</p> <p>For patients with a normal coagulation system, who experience serious bleeding, sound evidence for recombinant activated factor VII (rFVIIa) as an effective haemostatic agent is only scarcely available so far from controlled clinical...

Full description

Bibliographic Details
Main Authors: Wiedermann CJ, Pechlaner C, Eller P
Format: Article
Language:English
Published: BMC 2006-01-01
Series:Thrombosis Journal
Online Access:http://www.thrombosisjournal.com/content/4/1/1